David Sackler (House Television via AP Images)

Fed­er­al bank­rupt­cy judge ap­proves Pur­due Phar­ma and Sack­ler­s' $6 bil­lion opi­oid set­tle­ment

A US bank­rupt­cy judge on Wednes­day ap­proved Pur­due Phar­ma’s set­tle­ment plan that will see the Sack­lers pay up to $6 bil­lion to states and vic­tims of ad­dic­tion for their role in the opi­oid epi­dem­ic — which is a bil­lion more than a pre­vi­ous set­tle­ment that was tossed out in De­cem­ber.

The Sack­ler fam­i­ly, who owns Pur­due Phar­ma, will pay be­tween $5.5 bil­lion and $6 bil­lion over 18 years, ac­cord­ing to a re­cent state­ment from Con­necti­cut At­tor­ney Gen­er­al William Tong. And while the plan would put an end to civ­il claims against the fam­i­ly over Pur­due’s in­volve­ment in the opi­oid epi­dem­ic, it does not re­lease them from fu­ture crim­i­nal li­a­bil­i­ty.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.